from the Beckman Research Institute of City of Hope and coeditor of the Mary Ann Liebert journal, Oligonucleotides, talks with GEN’s Editor-in-Chief John Sterling about Oligonucleotides.

Previous articlePeter MacCallum Cancer Centre and Affymetrix Initiate Research Collaboration
Next articleFDA Approves Vectibix to Treat Patients with Metastatic Colorectal Cancer